The ability of the oxime HI-6 to reduce tabun-induced acute neurotoxic signs and symptoms was compared with the neuroprotective efficacy of two combinations of oximes (HI-6 + trimedoxime, HI-6 + K203) using a functional observational battery. Tabun-induced neurotoxicity and the neuroprotective effects of HI-6 alone, and HI-6 combined with trimedoxime or K203, in rats poisoned with tabun at a sublethal dose (200 μg/kg i.m.; 80% of LD 50 value), were monitored by the functional observational battery at 24 hours following tabun challenge. The results indicate that both oxime mixtures tested, combined with atropine are able to allow tabun-poisoned rats to survive for 24 hours following tabun challenge, while one non-treated tabun poisoned rat and one tabun-poisoned rat treated with the oxime HI-6 alone combined with atropine, died within 24 hours following tabun challenge. The oxime HI-6 alone, as well as both oxime mixtures combined with atropine, were able to decrease tabun-induced neurotoxicity in the case of sublethal poisonings, but they did not eliminate all tabun-induced acute neurotoxic signs and symptoms. Their ability to reduce tabun-induced acute neurotoxcicity was almost the same, regardless of type of antidotal treatment. Thus, the tested combinations of oximes were not able to increase the neuroprotective effectiveness of the antidotal treatment of acute tabun poisonings compared to the individual oxime.
INTRODUCTION
Nerve agents are considered to be the most dangerous chemical warfare agents. These compounds pose potential neurotoxic threats to both military and civilian populations as evidenced by actual terrorist attacks in Japan (Ohtomi et al. 1996) . Their acute toxic effects are based on the phosphonylation of acetylcholinesterase (AChE, EC 3.1.1.7), leading to the irreversible inhibition of its active site and subsequent overstimulation of postsynaptic cholinergic receptors due to the accumulation of the neurotransmitter acetylcholine in the synapses of the central and peripheral nervous systems (Lotti 2000 , Marrs 1993 ).
The medical countermeasures after nerve agent poisonings include the administration of the antidotes that are able to counteract the main toxic effects of nerve agents. The standard antidotal treatment of nerve agent poisoning usually includes an anticholinergic agent to block the overstimulation of  Jiří Kassa, Faculty of Military Health Sciences, Třebešská 1575, 500 01 Hradec Králové, Czech Republic  kassa@pmfhk.cz  +420 973 251 500  +420 495 518 094 muscarinic cholinergic receptors, and an oxime to reactivate nerve agent-inhibited AChE (Dawson 1994 , Taylor 1996 . Nerve agents can produce centrally-mediated seizure activity, that rapidly progresses to status epilepticus, and contributes to profound brain damage (Marrs 1993 , Taylor 1996 . The exposure of experimental animals to nerve agents in convulsion-inducing doses may result in irreversible lesions in the central nervous system (CNS), which can be manifested as behavioral effects in survivors that have convulsed (Jokanović 1993) . Therefore, the ability of antidotes to block the acute neurotoxic effects of nerve agents and prevent development of irreversible lesions in CNS, is important for successful antidotal treatment. Generally, the oximes exert more potent effects in the peripheral compared to the central nervous system, due to their poor penetration into CNS, although some published results have described the penetration of oximes into CNS and subsequent reactivation of nerve agent-inhibited AChE in the brain (Cassel et al. 1997 , Sakurada et al. 2003 ).
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The experience of stockpiling and use of a number of different nerve agents in Iraq and their use by terrorists in Japan (Ohtomi et al. 1996, Lawrence and Kirk 2007) emphasizes the necessity to introduce oximes with a broader spectrum. However, published results confirm that there is no single, broad-spectrum oxime suitable for the antidotal treatment of poisonings with all nerve agents (Bajgar 2005 , Marrs et al. 2006 . Therefore, the replacement of commonly used oximes (pralidoxime, obidoxime) as well as H-oximes (the oxime HI-6) with a more effective oxime with a broader spectrum has been a long-standing goal for the treatment of nerve agent poisoning. During the past several decades, many new oximes have been synthesized. Although some of them can be considered to be promising oximes against some nerve agents, none of them is sufficiently effective against all nerve agents regardless of their chemical structure. (Musílek et al. 2007a , Maxwell et al. 2008 . Two years ago, the oxime K203 [1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethyl pyridinium)-but-2-ene dibromide] (Fig. 1 ) was synthesized at our Department of Toxicology (Musílek et al. 2007b and its pharmacokinetics was studied . Based on the in vitro and in vivo evaluation of its reactivating, therapeutic and neuroprotective efficacy, it was considered to be a promising oxime against tabun but not against cyclosarin (Musílek et al. 2007c , Kassa et al. 2008a ,b, Kassa et al. 2009 , Kovarik et al. 2009 ).
Another way to increase the potency of antidotes to counteract the acute neurotoxic effects of nerve agents and broaden their spectrum is to combine chosen oximes in the antidotal treatment. In this study, the combination of HI-6 with trimedoxime or K203 was used. The neuroprotective efficacy of the chosen mixtures of oximes in combination with atropine was evaluated against tabun (O-ethyl-N,N-dimethyl phosphoramidocyanidate) because its acute neurotoxicity is extraordinarily difficult to antagonize due to the changes in hydrogen bonding and the conformational changes of the AChE-tabun complex prior aging process in the AChE active site that make the nucleophilic attack of oxime almost impossible Bajgar 1999, Ekström et al. 2006) .
The main aim of this study was to compare, in tabun-poisoned rats, the neuroprotective efficacy of the oxime HI-6, which is considered to be the oxime with the broadest spectrum among commonly used oximes, with two mixtures of oximes containing the oxime HI-6 and trimedoxime, or the oxime K203 in combination with the anticholinergic drug atropine. The tabun-induced neurotoxic signs were determined using a functional observational battery -a non-invasive and relatively sensitive type of neurological examination for a wide range of neurobiological functions including measurements of sensory, motor and autonomic nervous functions.
MATERIAL AND METHODS

Animals
Male albino Wistar rats weighing 220-250g were purchased from VELAZ (Prague, Czech Republic). They were kept in an air-conditioned room (22 ± 2 °C and 50 ± 10% relative humidity, with lights from 7.00 to 19.00 hr) and allowed access to standard food and tap water ad libitum. The rats were divided into groups of 8 animals. Handling of the experimental animals was performed in compliance with relevant laws and institutional guidelines and under the supervision of the Ethics Committee of the Faculty of Military Health Sciences in Hradec Králové (Czech Republic).
Chemicals and drugs
Tabun was obtained from the Military Technical Institute in Brno (Czech Republic) and was 98% pure as assayed by acidimetric titration. All oximes studied were of 98.5% purity and were synthesized at the Department of Toxicology of the Faculty of Military Health Sciences in Hradec Králové (Czech Republic) (Musílek et al. 2006 , 2007b ). Their purity was analyzed using HPLC. All other drugs and chemicals of analytical grade were obtained commercially and used without further purification. All substances were administered intramuscularly (i.m.) at a volume of 1 ml/kg body weight (b.w.).
Procedure of experiments
Tabun was administered at a sublethal dose (200 μg/kg b.w. -80% LD 50 ). One minute following tabun challenge, the rats were treated with atropine (21 mg/kg b.w.) in combination with the oxime HI-6 alone or with the combination of HI-6 and trimedoxime or K203 at equitoxic doses corresponding to 5% of their LD 50 values. The neurotoxicity of tabun was monitored using the functional observational battery at 24 hrs following tabun poisoning. The evaluated markers of tabun-induced neurotoxicity in the experimental animals were compared with the parameters obtained from the control rats given saline instead of tabun and antidotes at the same volume.
Functional observational battery
The functional observational battery consists of 44 measurements of sensory, motor and autonomic nervous functions. Some of them are scored (Table 1) , the others are measured in absolute units Hornychová 1995, Hornychová et al. 1995) . The first evaluation was obtained when tabun-poisoned rats were in the home cage. The observer evaluated each animal's posture, palpebral closure and involuntary motor movements. Then, each rat was removed from the home cage and briefly hand-held. The exploratory activity, piloerection and other skin abnormalities were noted. Salivation and nose secretion were also registered and scored. Then, the rats were placed on a flat surface which served as an open field. A timer was operated for 3 min during which the frequency of rearing responses was recorded. At the same time, gait characteristics were noted and ranked, and arousal, stereotypy and bizarre behaviours and abnormal posture were evaluated. At the end of the third min, the number of fecal boluses and urine pools on the adsorbent pad was registered. Reflex testing comprising recording each rat's response to the frontal approach of the blunt end of a pen, a touch of the pen to the posterior flank and an auditory clic stimulus was also used. The response to a pinch on the tail and the ability of pupils to constrict in response to light were then assessed. These measures were followed by a test for the aerial righting reflex and by the measurements of forelimb and hindlimb grip strength, body weight, body temperature and finally hindlimb landing foot splay. The whole battery of tests required approximately 6-8 min per rat. The observer of the behaviour did not know about the design of the experiments.
Data analysis
Data collected with the functional observational battery include categorial, ordinal and continuous values. Statistical analyses were performed on a PC with the special interactive programme NTX (Roth et al. 1962) . The significance level 2α´0.05 was used. 11 Tail-pinch response 2.00 2.00 2.00 1.00* 1.00* n = 8 n = 8 n = 8 n = 7 n = 7 15 Respiration 0.00 0.00 0.00 0.00 0.00 n = 8 n = 8 n = 8 n = 7 n = 7
RESULTS
All tabun-poisoned rats who were given the antidotal treatment of a mixture of oximes in combination with atropine, survived till the end of the experiment (24 hrs following intoxication). On the other hand, one non-treated tabun-poisoned rat and one tabun-poisoned rat treated with the oxime HI-6 alone in combination with atropine died within 24 hr after tabun challenge. The results of the experiments related to the measurement of tabun-induced neurotoxicity at 24 hr following tabun poisoning are divided into three parts [activity and neuromuscular measures, sensorimotor and excitability measures, and autonomic measures (Moser et al. 1997) ] and summarized in Tables 2a-c. The observation of neurotoxic signs indicated that many functional disorders in tabun-poisoned rats lasted at least 24 hr. Tabun produced passive behaviour in the rats during handling and retention, miosis and a decrease in muscular tone at 24 hrs following tabun administration. The exploratory and rearing activity were significantly decreased and gait was somewhat impaired. Tabun-poisoned rats were not able to constrict their pupils in response to light due to tabun-induced miosis. The approach and tail-pinch response disappeared. A significant decrease in landing foot splay, limb grip strength, food receiving and body temperature were also observed at 24 hrs following tabun challenge (Table 2a -c). The potency of the oxime HI-6 alone as well as the oxime HI-6 combined with trimedoxime or K203 to eliminate tabun-induced acute neurotoxic effects was similar and relatively low. The oxime HI-6 was able to eliminate the impairment of gait, the absence of approach response and miosis. When the mixture of HI-6 with trimedoxime or K203 was administered, observations showed the elimination of the absence of the approach and tail-pinch response and a decrease in rearing activity, landing foot splay and body temperature (Table 2a-c) .
DISCUSSION
Generally, the potency of currently available oximes to eliminate tabun-induced acute neurotoxic effects is low. Pralidoxime, a currently available oxime for the treatment of poisonings with highly toxic organophosphates (Dawson 1994), seems to be practically ineffective in preventing tabun-induced neurotoxicity (Kassa and Krejčová 2003) although its penetration into CNS is higher compared to the commonly used bispyridinium oximes such as obidoxime, trimedoxime or HI-6 (Cassel et al. 1997 , Sakurada et al. 2003 , Lorke et al. 2008 . Trimedoxime is able to partly eliminate tabun-induced acute neurotoxicity following i.m. administration of tabun at a sublethal dose, but its neuroprotective efficacy is limited (Kassa and Karasová 2007) . The oxime HI-6 was developed and introduced by some countries for the antidotal treatment of severe acute soman poisonings because of its higher reactivation and therapeutic efficacy compared to currently used oximes such as pralidoxime, obidoxime and trimedoxime (Dawson 1994, Kassa and . Nevertheless, it was demonstrated to be less efficacious in blocking tabun-induced acute neurotoxicity than trimedoxime and obidoxime (Kassa and Karasová 2007) . The unsatisfactory efficacy of the above mentioned oximes in eliminating tabun-induced acute neurotoxicity can be explained by the low potency of oximes in reactivating tabun-inhibited AChE in vitro and in vivo (Puu et al. 1986 , Jokanović et al. 1996 , Worek et al. 1998 . As no oxime has been developed to satisfactorily counteract the acute neurotoxicity of nerve agents regardless of their chemical structure, the combination of two oximes seems to be a rational means of ensuring the neuroprotective efficacy of the antidotal treatment of acute poisonings with nerve agents (including tabun) regardless of their chemical structure.
In combining oximes for the antidotal treatment of acute nerve agent poisonings, HI-6 should be considered to be the most important because it is the oxime with the broadest spectrum among the commonly used oximes. The HI-6 is sufficiently effective against many nerve agents but it is a weak reactivator of tabun-inhibited AChE (Worek et al. 1999 , Lundy et al. 2006 . Therefore, the second oxime included in the combination should be the oxime sufficiently effective against tabun. For our experiments, trimedoxime or the oxime K203 was chosen because trimedoxime has at least some effect against tabun-inhibited AChE ) and K203 has been found to be a promising oxime against tabun (Musílek et al. 2007c , Kassa et al. 2008a , Kovarik et al. 2009 ).
The in vitro evaluation of the potency of the combination of the two oximes in reactivating nerve agent inhibited AChE showed that combining two oximes had no negative effects on the reactivation of nerve agent-inhibited AChE and, in addition, it had a beneficial effect by broadening the spectrum of the individual oximes (Worek et al. 2007 ). These results correspond to in vivo results from mice, rats and guinea-pigs published by several authors (Clement et al. 1987 , Kovačević et al. 1989 , Maksimović and Kovačević 1989 . They found that the mixture of the oxime HI-6 and trimedoxime in the presence of atropine and diazepam ensures a higher degree of protection against poisoning by tabun, sarin and VX than the mixtures of HI-6 with pralidoxime or obidoxime (Kovačević et al. 1991) . The beneficial effects of the combination of oximes compared to a single oxime treatment in reactivating nerve agent-inhibited AChE could be explained by an elevated plasma oxime level and the synergetic effect of both oximes (Worek et al. 2007 ). Nevertheless, our results demonstrate that the combination of the oxime HI-6 with trimedoxime or K203 did not bring any beneficial effect for the potency of HI-6 in reducing the acute neurotoxic effects of tabun. Due to the limited penetration of oximes through the blood-brain barrier (BBB), the elevated plasma oxime level was probably not enough to significantly increase the penetration of oximes across BBB.
